Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | KRYSKrystal Biotech, Inc.FY2025 · Dec |
|---|---|
| Revenue | $389.13M |
| Revenue, yoy | +33.9% |
| Net income | $204.83M |
| Net income, yoy | +129.7% |
| Net margin | 52.6% |
| Free cash flow | $188.91M |
| FCF margin | 48.5% |
| EPS, diluted | $6.84 |
Add another company.